Not applicableStudy completedNCT01893398What this trial is testingMultistimulation Group Therapy for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Fondazione Don Carlo Gnocchi ETS 60
Not applicableStudy completedNCT00348309What this trial is testingRosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 1,496
Early research (Phase 1)Study completedNCT02754830What this trial is testingLY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)Who this might be right forAlzheimer's Disease Eli Lilly and Company 72
Not applicableUnknownNCT04021888What this trial is testingThe Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseAerobic ExerciseBreathing Exercise+1 more Dokuz Eylul University 60
Testing effectiveness (Phase 2)Study completedNCT01504854What this trial is testingResveratrol for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Alzheimer's Disease Cooperative Study (ADCS) 119
Testing effectiveness (Phase 2)Study completedNCT03493282What this trial is testingEffect of CT1812 Treatment on Brain Synaptic DensityWho this might be right forAlzheimer Disease Cognition Therapeutics 43
Testing effectiveness (Phase 2)Study completedNCT06694597What this trial is testingEfficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Fujian Medical University Union Hospital 76
Post-approval studies (Phase 4)UnknownNCT05383183What this trial is testingEfficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Daewoong Bio Inc. 630
Large-scale testing (Phase 3)Study completedNCT01614886What this trial is testingRandomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)Who this might be right forAlzheimer's Disease Novartis Pharmaceuticals 216
Large-scale testing (Phase 3)Ended earlyNCT00490568What this trial is testingOpen-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersWho this might be right forAlzheimer's Disease GlaxoSmithKline 1,461
Testing effectiveness (Phase 2)Ended earlyNCT06185543What this trial is testingA Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.Who this might be right forAlzheimer Disease NeuroSense Therapeutics Ltd. 8
Early research (Phase 1)Study completedNCT03822208What this trial is testingFirst in Human Study for Safety and Tolerability of AL003.Who this might be right forHealthyAlzheimer Disease Alector Inc. 54
Early research (Phase 1)Study completedNCT01397539What this trial is testingSingle Ascending Dose Study of BIIB037 in Participants With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Biogen 53
Early research (Phase 1)Study completedNCT04685265What this trial is testingAssess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's DiseaseWho this might be right forParkinson Disease MODAG GmbH 70
Testing effectiveness (Phase 2)Ended earlyNCT02322021What this trial is testingDose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementia, Alzheimer Type Eisai Inc. 70
Testing effectiveness (Phase 2)Study completedNCT01137526What this trial is testingEfficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 267
Large-scale testing (Phase 3)Study completedNCT00423085What this trial is testingEfficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Novartis Pharmaceuticals 859
Testing effectiveness (Phase 2)Study completedNCT01782742What this trial is testingBexarotene Amyloid Treatment for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease The Cleveland Clinic 20
Testing effectiveness (Phase 2)Ended earlyNCT01560585What this trial is testingOpen Label Study of Isotretinoin in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease University Hospitals Cleveland Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT00329082What this trial is testingEffects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy VolunteersWho this might be right forAlzheimer's Disease Eli Lilly and Company 25